Finally there seems to be some good news on the AIDS research front. This Monday the FDA has approved a drug, the very first of its kind, which aims to curb of nearly decades of onslaught of the HIV infection. This feat is a milestone and the entire credit goes to all the professionals who strived hard relentlessly to get to their goal that is to put an end or to conquer the HIV the virus that causes AIDS. It developed the tablet TRUVADA as a precautionary measure for those people who were more prone to the HIV via sexual intimacy, for instance people with HIV / AIDS infected partners.
The experts who were the part of the research say that this is a baby step in the slowing down of HIV infection that infects nearly 50000 people every year, all across the world. Even in the developed there are statistically 1.2 million cases reported. This is a welcome decision on the part of the FDA as doctors have been saying that new methods were needed to curb the spread of this infection. But research was falling short of a fool proof method, well so far.
The studies on Truvada were intensified 2 years back and the results showed that it helped HIV contraction when used as a safety measure; however proper sex education and condoms are a must to help Truvada accomplish its purpose. The study on gay and bisexual men showed that this medicine reduced their risk of contracting the HIV infection by 42% and by 75% in heterosexual men.
The FDA had no qualms about the efficacy of this medicine; however they were reluctant to approve it because of social reasons. They felt that people would become more reckless in their sexual activity after its approval. However it is safe to say that this drug is a start to the end of HIV.Tags: AIDS Research, HIV infection, Truvada